The Patent Finder

Opsona Therapeutics Limited

Also on record
Records under this name other than patents Opsona Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Opsona Therapeutics Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,580,255Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,234,046Treatment of renal disease
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,734,794Humanised antibodies to toll-like receptor 2 and uses thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,734,788Composition and method for treatment of reperfusion injury and tissue damage
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,896,497Toll-like receptor 2 binding epitope and binding member thereto
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,047,164Methods and Compositions for the Treatment of Pancreatic Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,414,887Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists
Lapsed on the fee record
Ended Apr 9, 2017 · USPTO record
Lapsed on the fee recordEnded Apr 9, 2017USPTO record
US 8,221,992Assays for determining compounds which modulate TRAM phosphorylation
Lapsed on the fee record
Ended Jul 17, 2016 · USPTO record
Lapsed on the fee recordEnded Jul 17, 2016USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited